Identifying Barriers to Statin Therapy in Diabetic Patients in a Large Ambulatory Practice

Aim 1: To understand the root cause(s) for gaps in statin therapy within a large ambulatory care practice. Aim 2: To improve provider awareness of indications for statin therapy, as recommended by the ACC/AHA guidelines. Aim 3: To increase the proportion of patients with diabetes at our practice that are on statin therapy

Scribes in Primary Care

To be covered Background of medical scribes in USA A place for scribes in primary care? Impact on physician productivity Impact on patient satisfaction Impact on progress note quality Impact on physician satisfaction Drawbacks of scribes in primary care Future direction

Non-Insulin Management of Type II Diabetes

Learning Objectives Understand a logical, evidence based algorithm for initiating antihyperglycemic therapy for Type II DM Understand drug specific effects and patient factors of the major classes of noninsulin diabetes pharmacological agents, including: Biguanides, Sulfonylureas, Thiazolidinediones, DPP-4 inhibitors, GLP-1 agonists, and SGLT2 Inhibitors Grasp basic understanding of the above pharmacological agents\u27 mechanisms of actio

The Workup and Management of Hypercalcemia in Primary Care

Learning Objectives Review the basic physiology of calcium homeostasis Understand a logical algorithm for working up hypercalcemia - an often incidental finding with a wide array of possible etiologies Review the evidence behind current management recommendation

Improving follow-up for family medicine patients after hospital discharge

Aims Increase percentage of JFMA patients with follow-up appointment scheduled after discharge to 100% by March 2018 Increase percentage of JFMA patients who show up to their follow up appointments after discharge to 80% by March 2018https://jdc.jefferson.edu/patientsafetyposters/1083/thumbnail.jp

Improving Diabetic Retinopathy Screening in a Large Ambulatory Practice

Aim 1: To increase the percentage of JFMA diabetic patients with up-to-date retinopathy screening to 60% by April 1, 2019. Aim 2: To increase the utilization of an in-office portable retinal scanner by identifying current barriers to its use and developing a standardized workflow to overcome these barriers. Outcome measure: The percentage of adult diabetic patients with a JFMA provider listed as the PCP who have been seen in the Jefferson health system within the last 24 months, who had retinopathy screening once in the last 24 months. Process measure: The number of retinal scans completed each week.https://jdc.jefferson.edu/patientsafetyposters/1143/thumbnail.jp